Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CBUS 
Cibus Global LLC (CBUS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/28/2025: CBUS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $14.4
1 Year Target Price $14.4
| 2 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -85% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 73.99M USD | Price to earnings Ratio - | 1Y Target Price 14.4 |
Price to earnings Ratio - | 1Y Target Price 14.4 | ||
Volume (30-day avg) 4 | Beta 1.62 | 52 Weeks Range 1.09 - 4.96 | Updated Date 11/29/2025 |
52 Weeks Range 1.09 - 4.96 | Updated Date 11/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date 2025-11-14 | When - | Estimate -0.18 | Actual -0.44 |
Profitability
Profit Margin - | Operating Margin (TTM) -2510.24% |
Management Effectiveness
Return on Assets (TTM) -12.9% | Return on Equity (TTM) -145.81% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 81745371 | Price to Sales(TTM) 19.5 |
Enterprise Value 81745371 | Price to Sales(TTM) 19.5 | ||
Enterprise Value to Revenue 21.55 | Enterprise Value to EBITDA -1.15 | Shares Outstanding 52707626 | Shares Floating 36584890 |
Shares Outstanding 52707626 | Shares Floating 36584890 | ||
Percent Insiders 33.42 | Percent Institutions 26.72 |
Upturn AI SWOT
Cibus Global LLC
Company Overview
History and Background
Cibus Global LLC, founded in 2001, focuses on developing advanced technologies for creating crop traits without the use of transgenic processes. It originated from research into plant genetics and evolved into a company specializing in precision gene editing and rapid trait development. A significant milestone includes the development of its Rapid Trait Development System (RTDS).
Core Business Areas
- Trait Development: Cibus develops and licenses novel crop traits, enhancing yield, disease resistance, and other desirable characteristics in various crops.
- Technology Platform: The company licenses its RTDS technology platform to other agricultural companies for their own trait development programs.
- Seed Production: Cibus engages in seed production for the varieties it develops.
Leadership and Structure
Peter Beetham serves as the CEO. The organizational structure includes departments focused on research and development, commercial operations, and licensing.
Top Products and Market Share
Key Offerings
- Product Name 1: Canola Traits (Olema): Herbicide tolerant canola varieties developed using RTDS. Revenue is difficult to determine precisely, but contributes significantly to Cibus's overall revenue through licensing and seed sales. Competitors include Bayer (BAYRY), BASF (BASFY), and Corteva (CTVA) which use traditional breeding and/or GMO technologies.
- Product Name 2: RTDS Licensing: Licensing of Cibus's RTDS technology platform to other companies and research institutions. Revenue is undisclosed, but crucial for the company's overall strategy and financial stability. Competitors include companies offering gene editing technologies like CRISPR companies such as CRISPR Therapeutics (CRSP), Editas Medicine (EDIT) and Intellia Therapeutics (NTLA).
Market Dynamics
Industry Overview
The agricultural biotechnology industry is experiencing growth driven by the need for higher crop yields, increased sustainability, and resistance to climate change. Gene editing technologies, like Cibus's RTDS, are becoming increasingly important. Market consolidation is ongoing, with large players acquiring smaller, innovative companies.
Positioning
Cibus is positioned as an innovator in non-GMO trait development. Its RTDS technology provides a unique competitive advantage over companies relying on transgenic methods. The company emphasizes precision and speed in trait development.
Total Addressable Market (TAM)
The total addressable market for agricultural biotechnology is estimated to be in the tens of billions of dollars. Cibus is positioned to capture a significant portion of this market by licensing its technology and developing novel crop traits. The TAM is large, and Cibus is focusing on a specific niche within this TAM with it's non-GMO focus.
Upturn SWOT Analysis
Strengths
- Proprietary RTDS technology
- Non-GMO approach appealing to certain markets
- Strong intellectual property portfolio
- Experienced leadership team
Weaknesses
- Reliance on licensing revenue
- Limited product portfolio compared to larger competitors
- Capital intensive R&D
- Regulatory hurdles in certain regions
Opportunities
- Expanding RTDS licensing to new crops and regions
- Developing new traits addressing climate change
- Partnering with larger agricultural companies
- Acquiring complementary technologies or companies
Threats
- Competition from established players with deeper pockets
- Changes in regulatory landscape for gene editing
- Patent disputes
- Adoption barriers for non-GMO technologies
Competitors and Market Share
Key Competitors
- BAYRY
- BASFY
- CTVA
- CRSP
- EDIT
- NTLA
Competitive Landscape
Cibus has advantages with its non-GMO RTDS technology, but it faces challenges competing against larger, established companies with broader product portfolios and greater financial resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is not available due to the company's private status.
Future Projections: Future growth projections are not publicly available and would depend on factors such as licensing agreements, trait development success, and market adoption.
Recent Initiatives: Recent initiatives include expanding RTDS licensing and developing new canola traits.
Summary
Cibus Global LLC, with its RTDS technology, possesses a unique advantage in the non-GMO trait development space. They need to increase licensing and revenue generation. Its smaller size compared to industry giants and regulatory hurdles pose challenges. Expanding partnerships and continued innovation are crucial for sustained growth and market share gain. Cibus needs to focus on key crops and traits to ensure success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Press Releases
- Analyst Estimates
Disclaimers:
The analysis is based on publicly available information and limited due to the company's private status. Market share data are estimates and may vary. Financial data and future projections are subject to change and inherent uncertainty.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cibus Global LLC
Exchange NASDAQ | Headquaters San Diego, CA, United States | ||
IPO Launch date 2023-06-01 | Co-Founder, Interim CEO, President, COO & Director Dr. Peter R. Beetham B.Sc., Ph.D. | ||
Sector Healthcare | Industry Biotechnology | Full time employees 157 | Website https://www.cibus.com |
Full time employees 157 | Website https://www.cibus.com | ||
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.